Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study-Reference-Cited by-同舟云学术

Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study

Published:2024-08 Issue:2 Volume:91 Page:255-258
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Hasan Iraj,Parsons Lauren,Duran Sabrina,Zinn Zachary

Publisher

Elsevier BV

Reference4 articles.

1. Dupilumab, atopic dermatitis, and mycosis fungoides-new insights on an evolving story;Guitart;JAMA Dermatol,2023

2. The risk of lymphoproliferative disorders and skin cancers in patients with psoriasis and inflammatory bowel disease administered biologics;Min;Dermatol Ther,2023

3. Dupilumab-associated lymphoid reactions in patients with atopic dermatitis;Boesjes;JAMA Dermatol,2023

4. Progression of cutaneous T-cell lymphoma after dupilumab: case review of 7 patients;Espinosa;J Am Acad Dermatol,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to Hasan et al., “[Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T-cell lymphoma: a retrospective cohort study]”;Journal of the American Academy of Dermatology;2024-09

2. Comments on the risk of cutaneous T cell lymphoma among patients with atopic dermatitis receiving dupilumab;Journal of the American Academy of Dermatology;2024-08

3. Response to Hasan et al, “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study”;Journal of the American Academy of Dermatology;2024-08

4. Multisystem Langerhans Cell Histiocytosis following Treatment of Initially Presumed Atopic Dermatitis with Dupilumab: A Case Report of an Extremely Confusing Scenario;Case Reports in Dermatology;2024-07-01

5. Response to Hasan et al’s “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study”;Journal of the American Academy of Dermatology;2024-07